← Evidence map

ArticleFrontiers in nutrition2026

Serum fibroblast growth factor 21 is a novel biomarker of cachexia in chronic liver disease.

Takatsugu Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41788683